31-Dec-2025
No headlines found.
Business Wire (Tue, 16-Dec 8:54 AM ET)
Haleon Recognized by Fast Company as a 2025 Brands That Matter Honoree
Business Wire (Fri, 12-Dec 9:26 AM ET)
Altibbi Enables Haleon's "Healthy Saudi Smile" Campaign, Turning Oral Health Awareness Into Action
PRNewswire (Mon, 24-Nov 6:17 AM ET)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Haleon PLC American Depositary Shares (Each Representing Two Ordinary Shares) trades on the NYSE stock market under the symbol HLN.
As of December 31, 2025, HLN stock price climbed to $10.11 with 4,104,136 million shares trading.
HLN has a beta of 0.18, meaning it tends to be less sensitive to market movements. HLN has a correlation of 0.03 to the broad based SPY ETF.
HLN has a market cap of $45.04 billion. This is considered a Large Cap stock.
In the last 3 years, HLN traded as high as $11.42 and as low as $7.49.
The top ETF exchange traded funds that HLN belongs to (by Net Assets): PPH, QLTI, AVDE, RGEF, AQEC.
HLN has underperformed the market in the last year with a return of +7.8%, while SPY returned +17.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in HLN shares. However, HLN has outperformed the market in the last 3 month and 2 week periods, returning +12.7% and +3.0%, while SPY returned +2.7% and +1.9%, respectively. This indicates HLN has been having a stronger performance recently.
HLN support price is $9.96 and resistance is $10.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HLN shares will trade within this expected range on the day.